Qualigen Therapeutics Inc Stock
Qualigen Therapeutics Inc Stock price
Key metrics
| Market capitalization | $4.67m |
| Enterprise Value | $6.22m |
| P/E (TTM) P/E ratio | negative |
| P/B ratio (TTM) P/B ratio | negative |
| Revenue growth (TTM) Revenue growth | -100.00% |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-8.21m |
| Cash position | $120.00k |
| EPS (TTM) EPS | $-1.61 |
Is Qualigen Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.
Qualigen Therapeutics Inc Stock Analysis
Analyst Opinions
1 Analyst has issued a forecast Qualigen Therapeutics Inc:
Analyst Opinions
1 Analyst has issued a forecast Qualigen Therapeutics Inc:
Financial data from Qualigen Therapeutics Inc
| Jun '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -8.20 -8.20 |
48%
48%
|
EBIT (Operating Income) EBIT | -8.21 -8.21 |
49%
49%
|
| Net Profit | -9.01 -9.01 |
49%
49%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Qualigen Therapeutics Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Qualigen Therapeutics Inc Stock News
Company Profile
Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARS™. ALAN (AS1411-GNP) is a DNA coated gold nanoparticle cancer drug candidate that has the potential to target various types of cancer with minimal side effects. RAS-F3 is a small molecule RAS oncogene protein-protein inhibitor for blocking RAS mutations that lead to tumor formation, especially in pancreatic, colorectal and lung cancers. STARS is a DNA/RNA-based treatment device for removal from circulating blood of precisely targeted tumor-produced and viral compounds. The company is headquartered in Los Angeles, CA.
| Head office | United States |
| CEO | Kevin Richardson |
| Employees | 4 |
| Founded | 2004 |
| Website | qlgntx.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
